“In terms of public figures and still more women in the cannabis world, whether it’s on stage at [MJBizCon] or launching their own brands or whatever it is, we’re seeing more women,” said Chloe Steerman, an Account Executive at Colorado-based Grasslands, a journalism-minded PR agency in the cannabis space that’s gone to great lengths to elevate the voices of women into leadership roles. “We’re just not seeing them in those positions of leadership and positions of power.”

Protesting residents of the mostly white, working-class neighborhoods of Holmesburg and Mayfair in Northeast Philadelphia accepted back in 2013 that methadone clinics were needed to help people with opioid use disorders. The caveat, according to them, was that they didn’t belong near churches, daycares or schools—or anywhere near the residential zones and revitalizing business centers where people in Northeast Philly live and work.

Dr. Shover, a postdoctoral research fellow at Stanford University worked with fellow researchers Corey Davis, Sanford Gordon, and Keith Humphreys to buck a cannabis industry pearl of conventional wisdom; the oft-cited, often-sloganeered study by Marcus Bachhuber that found a positive correlation between medical cannabis states and a decrease in opioid overdose deaths from 1999-2010.